Consist with that, GSEA showed that the PI3K‐AKT‐mTOR pathway was the only upregulated pathway in both tumor tissues of endocrine‐insensitive patients and endocrine‐resistant breast cancer cells (Figure S4D, Supporting Information). This evidence concerns the gene MTOR and breast carcinoma.